Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi.

Al Kaabi N, Yang Y, Eldin Hussein S, Yang T, Abdalla J, Wang H, Lou Z, Chinese Center For Disease Control And Prevention, Bakkour A, Arafat A, China National Biotec Group Company Limited, Jiang Z, Tian Y, National Engineering Technology Research Center For Combined Vaccines Wuhan Institute Of Biological Products Co Ltd, Beijing Institute Of Biological Products Company Limited, Xiao P, Zaher W, Eltantawy I, Wang C, Xu G, Zhang Y, Yang X

Open source

DOI: 10.3390/vaccines11020299
Published: 2023 Jan 30
Container: Vaccines
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/vaccines11020299,
  title = {Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi.},
  author = {Al Kaabi N and Yang Y and Eldin Hussein S and Yang T and Abdalla J and Wang H and Lou Z and Chinese Center For Disease Control And Prevention and Bakkour A and Arafat A and China National Biotec Group Company Limited and Jiang Z and Tian Y and National Engineering Technology Research Center For Combined Vaccines Wuhan Institute Of Biological Products Co Ltd and Beijing Institute Of Biological Products Company Limited and Xiao P and Zaher W and Eltantawy I and Wang C and Xu G and Zhang Y and Yang X},
  year = {2023},
  journal = {Vaccines},
  doi = {10.3390/vaccines11020299},
  url = {https://doi.org/10.3390/vaccines11020299}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi.
AU  - Al Kaabi N
AU  - Yang Y
AU  - Eldin Hussein S
AU  - Yang T
AU  - Abdalla J
AU  - Wang H
AU  - Lou Z
AU  - Chinese Center For Disease Control And Prevention
AU  - Bakkour A
AU  - Arafat A
AU  - China National Biotec Group Company Limited
AU  - Jiang Z
AU  - Tian Y
AU  - National Engineering Technology Research Center For Combined Vaccines Wuhan Institute Of Biological Products Co Ltd
AU  - Beijing Institute Of Biological Products Company Limited
AU  - Xiao P
AU  - Zaher W
AU  - Eltantawy I
AU  - Wang C
AU  - Xu G
AU  - Zhang Y
AU  - Yang X
PY  - 2023
JO  - Vaccines
DO  - 10.3390/vaccines11020299
UR  - https://doi.org/10.3390/vaccines11020299
ER  -

APA

N, A. K., Y, Y., S, E. H., T, Y., J, A., H, W., Z, L., Prevention, C. C. F. D. C. A., A, B., A, A., Limited, C. N. B. G. C., Z, J., Y, T., Ltd, N. E. T. R. C. F. C. V. W. I. O. B. P. C., Limited, B. I. O. B. P. C., P, X., W, Z., I, E., C, W., G, X., Y, Z., & X, Y. (2023). Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi.. Vaccines. https://doi.org/10.3390/vaccines11020299

Source records

pubmed · retrieved 2026-09-26T20:48:00.708Z
europe-pmc · retrieved 2026-09-26T20:48:00.727Z
doaj · retrieved 2026-09-26T20:48:00.720Z